Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The G-protein-coupled receptor (GPCR) signaling pathway is a fundamental mechanism by which cells sense and respond to a wide variety of external signals, including hormones, neurotransmitters, odors, light, and more. GPCRs are the largest family of membrane receptors in eukaryotes and play critical roles in numerous physiological processes such as vision, taste, smell, mood regulation, immune responses, metabolism, and behavior. Dysfunction in this pathway is implicated in diseases such as diabetes mellitus type 2, obesity, depression/anxiety disorders, cancer progression/metastasis and neurodegenerative diseases like Alzheimer’s disease. Over 500 FDA-approved drugs act via these pathways making them attractive for therapeutic intervention.
Modulation of intracellular effectors such as adenylyl cyclase or phospholipase C via G protein activation, leading to second messenger generation and downstream kinase activation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-protein-coupled receptor signaling pathway (GPCR pathway).